Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10060
Gene Symbol: ABCC9
ABCC9
0.100 Biomarker phenotype HPO
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.010 GeneticVariation phenotype BEFREE High prevalence of DD genotype in ARVD patients with syncope suggests that ACE I/D polymorphism might be useful in identifying high-risk patients for syncope. 19126662 2008
Entrez Id: 70
Gene Symbol: ACTC1
ACTC1
0.010 GeneticVariation phenotype BEFREE De novo mutations in ACTC were identified in two patients with sporadic HCM who presented with syncope in early childhood. 10966831 2000
Entrez Id: 86
Gene Symbol: ACTL6A
ACTL6A
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 133
Gene Symbol: ADM
ADM
0.010 Biomarker phenotype BEFREE Older age (β=0.13; SE=0.03, P<0.001), higher supine systolic blood pressure (β=0.06; SE=0.03, P=0.02), and higher supine midregional fragment of pro-adrenomedullin predicted longer time to syncope (β=2.31; SE=0.77, P=0.003), whereas supine levels of other neurohormones were not associated with time to syncope. 31208249 2019
Entrez Id: 135
Gene Symbol: ADORA2A
ADORA2A
0.020 AlteredExpression phenotype LHGDN Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope. 17599669 2007
Entrez Id: 135
Gene Symbol: ADORA2A
ADORA2A
0.020 GeneticVariation phenotype BEFREE Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. 19386617 2009
Entrez Id: 11216
Gene Symbol: AKAP10
AKAP10
0.100 Biomarker phenotype HPO
Entrez Id: 10142
Gene Symbol: AKAP9
AKAP9
0.100 Biomarker phenotype HPO
Entrez Id: 213
Gene Symbol: ALB
ALB
0.020 Biomarker phenotype BEFREE Using administrative health care databases, we examined the association of estimated glomerular filtration rate (eGFR) and urine albumin to creatinine ratio (ACR) with incident syncope and the association of incident syncope with the composite outcome of myocardial infarction, stroke, and death by levels of eGFR/ACR, using adjusted Cox proportional hazards models. 30527152 2018
Entrez Id: 213
Gene Symbol: ALB
ALB
0.020 Biomarker phenotype BEFREE NOBLADS comprises the following factors: non-steroidal anti-inflammatory drug use, no diarrhea, no abdominal tenderness, blood pressure ≤ 100 mmHg, antiplatelet drug use, albumin < 3.0 g/dL, disease score ≥ 2, and syncope. 29698506 2018
Entrez Id: 144245
Gene Symbol: ALG10B
ALG10B
0.100 Biomarker phenotype HPO
Entrez Id: 287
Gene Symbol: ANK2
ANK2
0.110 Biomarker phenotype HPO
Entrez Id: 287
Gene Symbol: ANK2
ANK2
0.110 GeneticVariation phenotype BEFREE All genotype-negative LQTS cases hosting ANK2 variants had been diagnosed as "atypical" or "borderline" cases, most presenting with normal QTc, nonexertional syncope, U waves, and/or sinus bradycardia. 16253912 2005
Entrez Id: 25820
Gene Symbol: ARIH1
ARIH1
0.010 Biomarker phenotype BEFREE ARI(t) increased significantly in AF patients (5.7 ± 1.2 versus 6.9 ± 1.2, p = 0.040) and VVS (5.8 ± 1.2 versus 7.3 ± 1.2, p = 0.015) in response to ABP fall during syncope. 28681121 2017
Entrez Id: 659
Gene Symbol: BMPR2
BMPR2
0.010 GeneticVariation phenotype BEFREE We report a novel frameshift mutation (c.117InsT, p.Y40fsX48) of the BMPR2 gene identified in a 19-year-old IPAH patient with syncope. 31626133 2019
Entrez Id: 317716
Gene Symbol: BPIFA4P
BPIFA4P
0.010 Biomarker phenotype BEFREE An anonymous online survey invited adult HCM patients to report participation in 11 activities (rollercoaster riding, jet skiing, rafting, bungee jumping, rappelling, paragliding, kayaking/canoeing, motor racing, snowboarding, BASE jumping and skydiving) before and after HCM diagnosis, along with major (ICD shock, syncope) or minor (nausea, dizziness, palpitations, chest pain) adverse events related to participation, and relevant physician advice. 31152873 2019
Entrez Id: 11149
Gene Symbol: BVES
BVES
0.100 Biomarker phenotype HPO
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.410 Biomarker phenotype HPO
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.410 Biomarker phenotype GENOMICS_ENGLAND Emerging therapeutic targets in the short QT syndrome. 29697308 2018
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.410 GeneticVariation phenotype BEFREE We studied a five-generation family, in which a CACNA1C variant c.2573G>A p.Arg858His co-segregates with syncope and cardiac arrest, documenting electrocardiographic data and cardiac symptomatology. 30345660 2019
Entrez Id: 781
Gene Symbol: CACNA2D1
CACNA2D1
0.100 Biomarker phenotype HPO
Entrez Id: 783
Gene Symbol: CACNB2
CACNB2
0.100 Biomarker phenotype HPO
Entrez Id: 801
Gene Symbol: CALM1
CALM1
0.100 Biomarker phenotype HPO
Entrez Id: 805
Gene Symbol: CALM2
CALM2
0.100 Biomarker phenotype HPO